武田制药第三季度盈利预览

2026-01-29 00:20

Takeda Pharmaceutical (TAK) is scheduled to announce Q3 earnings results on Thursday, January 29th, before market open.
Analysts on average of GAAP EPS of JPY 43.14 on revenue of JPY 1.193T.

More on Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited (TAK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Takeda Pharmaceutical Company Limited (TAK) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
Takeda: Lack Of Realistic Upside In Japanese Pharma
Halozyme, Takeda in arrangement to use former's drug delivery tech in Entyvio
Takeda, XOMA ink new royalty agreement; amend existing deal